alexa Cardiotoxicity of oncological treatment in children.
Cardiology

Cardiology

Journal of Clinical & Experimental Cardiology

Author(s): Kucharska W, NegruszKawecka M, Gromkowska M

Abstract Share this page

Abstract The incidence of complications after antineoplastic therapy is increasing in relation to the incidence of cancer and prolonged survival rate. Cardiotoxicity is one of the major complications, and it may occur during the therapy or many years after its termination, often leading to heart failure. Cardiotoxicity has been attributed particularly to cytostatics from the group of anthracycline antibiotics and radiotherapy, which are widely used in oncological treatment. The risk of developing cardiac complications depends on the cumulative dose of anthracyclines and the dose of chest irradiation, accompanying heart disorders, patient's age and sex. Acute myocardial damage occurs in the form of myocarditis and pericarditis. Late cardiotoxicity of anthracyclines manifests itself in the form of congestive cardiomyopathy, and late complications after radiotherapy also as valvular damage or restrictive cardiomyopathy. The incidence of asymptomatic myocardial dysfunction has been described in literature to range from 18 to 57\% on long-term follow up of children after oncological treatment, and about 5\% of children develop heart failure. For these reasons, attempts to develop schemes for monitoring patients after termination of antineoplastic treatment have been undertaken. The standards should include ECG, chest X-ray and echocardiography performed prior to, during and after oncological therapy. Biochemical markers, such as troponin or natriuretic peptide, may prove helpful. The frequency of cardiac function monitoring depends on the underlying risk. Long-term follow up of patients who have undergone antineoplastic therapy in childhood is recommended, with special attention paid to individual risk factors. The follow-up should also consider additional, well-known risk factors for cardiovascular diseases.
This article was published in Adv Clin Exp Med and referenced in Journal of Clinical & Experimental Cardiology

Relevant Expert PPTs

Relevant Speaker PPTs

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords